Astra vaccine unmasks EU divides between west and desperate east

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

When European drug regulators recognized the link between AstraZeneca Plc’s Covid-19 vaccine and a rare type of blood clot, it spread another dose of skepticism across the continent. But in the poorer east, doubt is more about the findings than the shot.

Most Western members of the European Union have announced some restrictions on the use of the vaccine for younger age groups or discontinued it altogether. The opposite is happening across the east, with nine of the 11 countries in the region deciding to keep the shot to all adults.

“Let us not create unnecessary panic,” said Bulgarian Health Minister Kostadin Angelov, citing the benefits of Astra medicine. “Let us not become part of the war between the different companies, because it is already visible.”

The former Eastern bloc houses almost a quarter of the EU’s 440 million inhabitants struggling to tame the pandemic. For these countries – what the world’s top 10 list of deaths per crown virus per capita – the restriction of a vaccine that is the key to their stock is unthinkable because they can not afford to delay the vaccination. Germany, by comparison, the number of daily vaccinations against Covid-19 doubled, while France reached a major milestone a week early.

Divided continent

Europe does not succeed in mapping the joint rate of Astra vaccine side effects

Source: Bloomberg


The world is counting on the Astra shot because of its price and ease of use, and it represents the most vaccines ordered by about a third of Eastern EU members. The vaccine is more easily transported and stored than the mRNA vaccines from Moderna Inc. and Pfizer-BioNTech, and the Anglo-Swedish company has promised to deliver as many as 3 billion shots on a non-profit basis by 2021.

Read more: AstraZeneca vaccine risks prolong pandemic

Hungary, which deviates from the EU-orchestrated procurement program and vaccines purchased directly from Russia and China also sought to express its support for Astra.

“The debate over the vaccination of AstraZeneca should be seen as a business dispute between drug manufacturers rather than valid opinions on medical risks,” Gergely Gulyas, the prime minister’s office, said on April 8.

A day earlier, EU and UK regulators said there was a possible link between the Astra shot and blood clots, although both have said that the benefits to most people outweigh the coronavirus. Britain, was she The vaccination program is much higher than the rest of the continent, and now recommends that those under thirty get another one.

BULGARIA-HEALTH-VIRUS VACCINATION

A healthcare worker checks a patient’s health before administering the AstraZeneca vaccine at the mayor’s office in the village of Gardevtsi, Bulgaria.

Photographer: Nikolay Doychinov / AFP / Getty Images

In Bulgaria, the poorest and least vaccinated country in the EU, the more expensive vaccines have been used to vaccinate priority groups such as doctors and teachers. Astra is the most widely available to the general public.

The country’s vaccination effort was already deficient due to poor organization and a refusal rate of 37% among its 7 million citizens to be vaccinated, according to a poll by Exacta Research in March. Bulgaria will continue to apply the Astra shot to all age groups, but offer another slap in the face to women at high risk for thrombosis, in line with the EMA’s recommendations, the health minister said.

.Source